Ontology highlight
ABSTRACT: Introduction
It is unclear whether quantitating muscle endurance adds nonredundant information useful for the care of patients with muscular disease.Methods
Records were retrospectively reviewed for all Johns Hopkins Myositis Center patients with a muscle endurance assessment (n?=?128, 226 patient-visits). Muscle endurance and strength were quantitated with the Myositis Functional Index-2 (FI2) and manual muscle testing (MMT), respectively.Results
Composite FI2 muscle endurance scores were comparable in inclusion body myositis (n?=?58), dermatomyositis (n?=?31), and polymyositis (n?=?39). Overall, muscle endurance correlated with and evolved similarly to strength, inversely to serum creatine kinase. However, in patients with normal or near-normal strength (mean MMT?>?9.75/10), muscle endurance was typically abnormal and highly variable (mean FI2, 5.6/10; interquartile range, 3.3-7.8/10).Discussion
Muscle endurance testing may identify muscle impairment inadequately described by MMT, particularly in patients with high MMT scores. Muscle Nerve 59:70-75, 2019.
SUBMITTER: Amici DR
PROVIDER: S-EPMC7951326 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Amici David R DR Pinal-Fernandez Iago I Pagkatipunan Ruben R Mears Albert A de Lorenzo Rebecca R Tiniakou Eleni E Albayda Jemima J Paik Julie J JJ Lloyd Thomas E TE Christopher-Stine Lisa L Mammen Andrew L AL Chung Tae T
Muscle & nerve 20181218 1
<h4>Introduction</h4>It is unclear whether quantitating muscle endurance adds nonredundant information useful for the care of patients with muscular disease.<h4>Methods</h4>Records were retrospectively reviewed for all Johns Hopkins Myositis Center patients with a muscle endurance assessment (n = 128, 226 patient-visits). Muscle endurance and strength were quantitated with the Myositis Functional Index-2 (FI2) and manual muscle testing (MMT), respectively.<h4>Results</h4>Composite FI2 muscle end ...[more]